-transparent.png){kind=logo}
The main parameters (reactogenicity, harmlessness, immunogenicity and prophylactic efficacy) of experimental batches of the inactivated influenza vaccine A, purified and concentrated on sodium-boron-silicate glass, were studied in strictly controlled epidemiological trial. In single subcutaneous injection in a dose of 0.5 ml (5120 hemagglutinating units) of the vaccine it was characterized by a moderate reactogenicity, marked antigenicity and prophylactic, efficacy.
Related Publications
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1976,
Trudy Instituta imeni Pastera,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1976,
Trudy Instituta imeni Pastera,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
March 1945,
Science (New York, N.Y.),
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1973,
Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
December 2018,
Archives of Razi Institute,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
September 1976,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1976,
Trudy Instituta imeni Pastera,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1976,
Trudy Instituta imeni Pastera,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1976,
Trudy Instituta imeni Pastera,
A A Sumarokov, and
V I Agafonov, and
V S Perepelkin, and
L A Nefedova, and
L V Salmin
January 1973,
Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
